LiblomycinAlternative Names: NK 313
Latest Information Update: 07 Feb 1996
At a glance
- Originator Nippon Kayaku
- Class Cytostatic antibiotics; Glycopeptides
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 07 Feb 1996 The WHO and EphMRA ATC codes for cancer are L01D C and L1D, respectively